AngioDynamics Inc reports results for the quarter ended in February - Earnings Summary

AngioDynamics

04/04/2024 14:32

* AngioDynamics Inc  ANGO.OQ  reported a quarterly adjusted
loss
of 16 cents​​ per share for the quarter ended in February, lower
than the same quarter last year, when the company reported EPS
of -3 cents.  The mean expectation of four analysts for the
quarter was for a loss of 14 cents per share. Wall Street
expected results to range from -18 cents to -11 cents per share.
    * Revenue fell 6.9% to $75.18 million from a year ago;
analysts
expected $75.73 million. 
    * AngioDynamics Inc's reported EPS for the quarter was a
loss of
$4.73​.
    * The company reported a quarterly loss of $190.44 million.
    * AngioDynamics Inc shares had risen by 3.6% this
quarter and
lost 22.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 67%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AngioDynamics Inc
is $14.00 
This summary was machine generated from LSEG data April 4 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Feb. 29 2024      -0.14          -0.16          Missed
 Nov. 30 2023      -0.07          -0.05          Beat
 Aug. 31 2023      -0.13          -0.12          Beat
 May. 31 2023      0.02           0.02           Met